The contract has enabled Forma to acquire a covalent chemistry platform developed by Dr Huib Ovaa. Dr Huib Ovaa is principal investigator of Chemical Biology Laboratories at NKI and a member of FORMA's deubiquitinase investigator network.
This indicates a distinct and additional agreement between FORMA and Dr Ovaa, with the first agreement signed in the area of DUBs in July 2013.
(22) Bai, Z., Cai, L., Umemoto, E., Takeda, A., Tohya, K., Komai, Y., Veeraveedu, P.T., Hata, E., Sugiura, Y., Kubo, A., Suematsu, M., Hayasaka, H., Okudaira, S., Aoki, J., Tanaka, T., Albers, H.M.,
Ovaa, H.